Cancer Sample Preparation with Micromachined Magnetic Sifter and Nanoparticles

使用微机械磁力筛和纳米颗粒制备癌症样品

• 批准号: 7857123
• 负责人: SHAN X. WANG
• 金额: $ 19.71万
• 依托单位: STANFORD UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-04-01 至 2013-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7857123
• 关键词: Acute; Address; Affinity; Albumins; Antibodies; Area; Biochemistry; Biological; Biological Assay; Biological Markers; Biosensor; Blood; Blood specimen; Cancer Diagnostics; Cell Culture Techniques; Cell Size; Cell secretion; Cells; Clinical; Collection; Communities; Complex; Coupled; Cytolysis; Detection; Diagnostic; Dimensions; Exhibits; Film; Fluorescence; Fluorescence-Activated Cell Sorting; Grant; Harvest; Hematologic Neoplasms; Hour; Human; Investigation; Label; Laboratories; Liquid substance; Magnetism; Malignant Neoplasms; Malignant neoplasm of lung; Mass Spectrum Analysis; Methods; Microscopy; Molecular; Molecular Diagnosis; Nanotechnology; Noise; Optics; Outcome; Patients; Performance; Positioning Attribute; Preparation; Procedures; Process; Protein Analysis; Protein Microchips; Proteins; Proteomics; Protocols documentation; Reagent; Reproducibility; Research; Running; Sampling; Sensitivity and Specificity; Serum; Shapes; Signal Transduction; Solid; Solid Neoplasm; Solutions; Speed; Structure; TNF gene; Techniques; Technology; Tube; Validation; Variant; Work; anticancer research; base; cancer cell; cancer stem cell; cell injury; cell type; clinical practice; cost; cross reactivity; design and construction; fighting; implantation; improved; innovation; innovative technologies; iron oxide; magnetic field; nano; nanometer; nanoparticle; neoplastic cell; novel; oncology; particle; peripheral blood; quantum; research study; sample collection; tool; tumor

DESCRIPTION (provided by applicant): Variations in sample preparation may contribute to major discrepancies in the quantity and type of biomolecules or cells identified by different laboratories, even though the same reagents and biosensors (or biochips) are employed. This is especially hampering our efforts to fight cancer as sample preparation is a prerequisite for cancer biomarker discovery, validation, and their use in molecular diagnosis and treatment of patients. This urgent need for cancer sample preparation requires innovative methods to bring about better and more affordable sample preparation tools. We have formed an interdisciplinary team with expertise from magnetics, nanotechnology, cancer clinical practice and research, biochemistry, and proteomics to work on a novel micromachined magnetic sifter and directly fabricated magnetic nanoparticles. The magnetic sifter can be used to separate and enrich cancer targets; including proteins and rare cells from raw samples. The utilization of precisely dimensioned structures, including the use of sub-nanometer control of quantum magnetic effects will enable high throughput, high capture yield, low impurities, and low cost. The technology is very unique because high magnetic field gradients (>1 Tesla/ 5m) and large flow rates (>1 mL/hour) are enabled by three-dimensional Si-based micromachining. The use of high-moment magnetic nanoparticles with distinctive shapes and controlled magnetic chain formation give rise to unprecedented capture and release efficiencies, cell damage minimization, enhanced characterization, and run-to-run reproducibility. The proposed project is organized in three aims: Specific Aim 1. Magnetic sifter for high efficiency capture and analysis of protein cancer markers and cancer cells: a) Construct a magnetic sifter with a high magnetic field gradient (>1 Tesla/ 5m) and large flow rate (>1 mL/hour) and demonstrate the efficient capture, release and analysis of protein cancer markers. b) Use magnetic sifter to capture and release NCI-H1650 lung cancer tumor cells cancer cells spiked into samples of human blood with an overall capture efficiency of >70%, while keeping cells viable. Specific Aim 2. Functionalization and characterization of novel magnetic nanoparticles for high efficiency high speed magnetic separation. Specific Aim 3. Magnetic sifter for rare cells capture and analysis from human blood. The utility of the grant includes drastically reducing post-separation analysis and enabling new investigations in areas where rare molecules and cell types are currently too difficult to obtain and analyze. Furthermore, separating protein and cancer markers from high concentration impurities in blood, with 1000-fold enrichment, will enable detection of low abundance cancer markers which are difficult to quantify with conventional technologies. We expect that the tools developed under this grant will have a great impact on the cancer research and treatment community.

描述（由申请人提供）：即使使用相同的试剂和生物传感器（或生物芯片），样品制备的差异也可能导致不同实验室鉴定的生物分子或细胞的数量和类型存在重大差异。这尤其阻碍了我们对抗癌症的努力，因为样品制备是癌症生物标志物发现、验证及其在患者分子诊断和治疗中的应用的先决条件。这种对癌症样品制备的迫切需求需要创新的方法来带来更好和更实惠的样品制备工具。我们组建了一个跨学科团队，拥有磁学，纳米技术，癌症临床实践和研究，生物化学和蛋白质组学的专业知识，致力于开发新型微机械磁筛和直接制造的磁性纳米颗粒。磁筛可用于分离和富集癌症靶点，包括来自原始样品的蛋白质和稀有细胞。利用精确尺寸的结构，包括使用量子磁效应的亚纳米控制，将实现高通量、高捕获产率、低杂质和低成本。该技术是非常独特的，因为高磁场梯度（>1特斯拉/5米）和大流量（>1毫升/小时）是通过三维硅基微加工实现的。具有独特形状和受控磁链形成的高磁矩磁性纳米颗粒的使用产生了前所未有的捕获和释放效率、细胞损伤最小化、增强的表征和运行再现性。该项目有三个目标：具体目标1。用于蛋白质癌症标志物和癌细胞的高效捕获和分析的磁筛：a）构建具有高磁场梯度（>1特斯拉/5 m）和大流速（>1 mL/小时）的磁筛，并证明蛋白质癌症标志物的有效捕获、释放和分析。B）使用磁筛捕获和释放掺入人血液样本中的NCI-H1650肺癌肿瘤细胞癌细胞，总体捕获效率> 70%，同时保持细胞活力。具体目标2。用于高效高速磁分离的新型磁性纳米粒子的功能化和表征。具体目标3。用于人类血液中稀有细胞捕获和分析的磁筛。 该补助金的用途包括大幅减少分离后分析，并在目前难以获得和分析稀有分子和细胞类型的领域进行新的研究。此外，通过1000倍富集将蛋白质和癌症标志物与血液中的高浓度杂质分离，将能够检测难以用常规技术定量的低丰度癌症标志物。我们预计，在这笔赠款下开发的工具将对癌症研究和治疗社区产生重大影响。